We have located links that may give you full text access.
Electrophysiological findings during AF re-ablation: Extending from PV reconnection to sequential bipolar voltage map information.
Journal of Cardiovascular Electrophysiology 2020 Februrary 10
BACKGROUND: Left atrial substrate modification targeting low voltage zones (LVZ) is an ablation strategy that - in addition to pulmonary vein isolation (PVI) - tries to eliminate arrhythmogenic mechanisms harbored in such tissue. Electrophysiological findings at re-ablation include (i) PV re-connection, (ii) reconnection over previous substrate ablation, and (iii) de-novo LVZ.
OBJECTIVE: To study, prevalence and contribution of these arrhythmogenic electrophysiological entities in patients with AF recurrences.
METHODS: Consecutive patients with highly symptomatic AF undergoing index and re-ablation were included (n=113). In all patients PV reconnection, re-connection over previous substrate ablation and spontaneous de-novo LVZ were quantitatively assessed and integrated into an individual re-ablation strategy. Follow-up was based on continuous device monitoring.
RESULTS: At re-do procedure, 45 out of 113 (39.8%) patients showed PV re-connection as the only electrophysiological abnormality. Re-conduction over previous lines was the only electrophysiological abnormality in 8 out of 113 (7.1%) patients. Spontaneous de-novo LVZ was the only electrophysiological abnormality in 12 out of 113 (10.6%) patients. Combined findings of PV re-connection, line re-conduction, and/or spontaneous de-novo LVZ were seen in 40 out of 113 (35.4%) patients. No detectable electrophysiological abnormality was observed in 8 out of 113 (7.1%) patients. In univariate analysis none of the tested electrophysiological characteristics independently predicted the outcome after re-do.
CONCLUSIONS: In patients undergoing re-ablation we could show that re-conduction over previous substrate ablation as well as development of new low voltage areas are frequent findings besides classical PV reconnection - without a clear leading cause for recurrences. These findings impact re-ablation strategies as well the strategic focus during index procedures. This article is protected by copyright. All rights reserved.
OBJECTIVE: To study, prevalence and contribution of these arrhythmogenic electrophysiological entities in patients with AF recurrences.
METHODS: Consecutive patients with highly symptomatic AF undergoing index and re-ablation were included (n=113). In all patients PV reconnection, re-connection over previous substrate ablation and spontaneous de-novo LVZ were quantitatively assessed and integrated into an individual re-ablation strategy. Follow-up was based on continuous device monitoring.
RESULTS: At re-do procedure, 45 out of 113 (39.8%) patients showed PV re-connection as the only electrophysiological abnormality. Re-conduction over previous lines was the only electrophysiological abnormality in 8 out of 113 (7.1%) patients. Spontaneous de-novo LVZ was the only electrophysiological abnormality in 12 out of 113 (10.6%) patients. Combined findings of PV re-connection, line re-conduction, and/or spontaneous de-novo LVZ were seen in 40 out of 113 (35.4%) patients. No detectable electrophysiological abnormality was observed in 8 out of 113 (7.1%) patients. In univariate analysis none of the tested electrophysiological characteristics independently predicted the outcome after re-do.
CONCLUSIONS: In patients undergoing re-ablation we could show that re-conduction over previous substrate ablation as well as development of new low voltage areas are frequent findings besides classical PV reconnection - without a clear leading cause for recurrences. These findings impact re-ablation strategies as well the strategic focus during index procedures. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app